Financing Working Capital and Capital Expenditures Primarily with Internal Funds and Securing Liquidity
First written in FY2019. 8 of 20 entries say "Softened", first in FY2020. Latest entry: FY2026.
Tabikobo moved to the "Worse" side of this theme in 2020, 6 years before the typical company in this theme (2026).
10 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「In light of these circumstances, on 20 May 2026 the company entered into a commitment line agreement with MUFG Bank, Ltd. with a facility limit of ¥500 million and is working to secure on-hand liquidity.」
While relying primarily on on-hand funds and operating cash flow, the company introduced a commitment line guaranteed by the parent company, with a facility limit of ¥500 million and a one-year term, as a new means of securing liquidity. - FY2025RestatedAnnual report
「These funds are generally sourced from cash flow from operating activities, but the company’s basic policy is to obtain funding through borrowings from financial institutions or equity financing when necessary.」
The company continues its funding policy of primarily relying on operating cash flow while combining borrowings and equity financing as necessary. Cash flow from financing activities during the current fiscal year was an inflow of ¥0.01 million. - FY2024RestatedAnnual report
「The group’s main funding needs are working capital and capital expenditures. These funds are generally sourced from cash flow from operating activities, but the group’s basic policy is to obtain funding through borrowings from financial institutions or equity financing when necessary.」
The company continues its funding policy of primarily relying on operating cash flow while combining borrowings and equity financing as necessary. During the current fiscal year, it raised ¥619.736 million through the exercise of stock acquisition rights and ¥2,969.366 million through the issuance of new shares. - FY2024-Q4RestatedAnnual report
「Net assets at the end of the fourth quarter of the current consolidated fiscal year totaled ¥2,290.103 million, an increase of ¥3,342.483 million from the end of the previous consolidated fiscal year.」
The company continues to secure its financial base by combining equity financing with internal funds and operating cash flow, as capital and capital surplus increased through the issuance of new shares by private placement and the exercise of stock acquisition rights. - FY2024-Q3AdvancedAnnual report
「To further strengthen its financial base, the Company resolved at its board meeting held on 10 August 2023 to issue new shares through a third-party allotment, and payment of ¥3,000,000 thousand was completed on 31 October 2023.」
Payment for the new shares issued through the private placement was completed, implementing measures to stabilize the financial base through ¥3 billion in equity financing in addition to funds from operating activities and borrowings. - FY2024-Q1SoftenedAnnual report
「In addition, to strengthen its capital base, the company issued the third series of stock acquisition rights through a private placement in August 2022 and raised ¥418.192 million through their exercise during the first quarter of the current consolidated fiscal year. At a meeting of the board of directors held on 10 August 2023, it also resolved to issue new shares through a private placement to further strengthen its capital base.」
Compared with its previous policy of primarily relying on funds from operating activities, the company raised ¥418.192 million through the exercise of stock acquisition rights and resolved to conduct a private placement of 10,000,000 shares with a total issue price of ¥3,000 million. The uses of funds include repayment of borrowings, recruitment and advertising. - FY2023AdvancedAnnual report
「During the current consolidated fiscal year, the company issued the third series of stock acquisition rights through a private placement and raised ¥956.277 million through their exercise. It will continue to raise funds as necessary from time to time.」
In addition to operating cash flow and borrowings, the company raised ¥956.277 million through the exercise of the third series of stock acquisition rights. It has explicitly stated a policy of raising funds as necessary in the future. - FY2023-Q3AdvancedAnnual report
「In addition, to strengthen its capital base, the company issued the third series of stock acquisition rights through a private placement in August 2022. During the first 9 months of the current consolidated fiscal year, it raised ¥910.4 million through the exercise of these stock acquisition rights.」
The company raised ¥910.4 million through the exercise of the third series of stock acquisition rights during the first 9 months of the current consolidated fiscal year. In addition to funds from operating activities, it continues to raise capital through the exercise of stock acquisition rights. - FY2023-Q2AdvancedAnnual report
「Proceeds from the issuance of shares upon exercise of stock acquisition rights: ¥318.882 million」
Compared with its previous policy of primarily relying on internal funds and operating cash flow, the company raised ¥318.882 million in external funds through the exercise of the third series of stock acquisition rights. - FY2023-Q1SoftenedAnnual report
「In addition, the company plans to conduct a private placement through the grant of stock acquisition rights to further strengthen its capital base.」
The company plans to conduct an additional private placement as a source of funds supplementing cash flow from operating activities and borrowings. The uses of funds for the third series of stock acquisition rights are payment of deferred social insurance premiums and repayment of borrowings. - FY2022-Q2SoftenedAnnual report
「Net cash provided by financing activities in the cumulative second quarter of the current consolidated fiscal year was ¥812.796 million, including ¥812.580 million of proceeds from the issuance of shares through the exercise of stock acquisition rights, compared with ¥3,001.294 million in the same period of the previous year.」
Compared with its previous policy of primarily relying on cash flow from operating activities, the company raised ¥812.58 million in external funds through the exercise of stock acquisition rights during the quarter, continuing its reliance on external funding. - FY2022-Q1RestatedAnnual report
「Based on a funding plan that assumes the effects of COVID-19 may continue for an extended period, the group has reduced fixed costs, held discussions with financial institutions, and allocated and exercised stock acquisition rights for third parties, thereby establishing a system for securing business funds.」
The company continues to secure business funds through a combination of operating cash flow, fixed-cost reductions, discussions with financial institutions and the exercise of stock acquisition rights, rather than relying solely on funds from operating activities. - FY2021SoftenedAnnual report
「These funds are generally sourced from cash flow from operating activities, but the company’s basic policy is to obtain funding through borrowings from financial institutions or equity financing when necessary.」
Compared with its previous policy of primarily relying on operating cash flow, the company raised ¥3 billion through short-term borrowings, ¥500 million through long-term borrowings and ¥377.936 million through the exercise of stock acquisition rights, explicitly identifying borrowings and equity financing as sources of funds. - FY2021-Q3SoftenedAnnual report
「At a meeting of the board of directors held on 23 December 2020, the company resolved to issue its second series of stock acquisition rights through a private placement, with Morgan Stanley MUFG Securities Co., Ltd. as the allottee. Payment of the total issue price of the stock acquisition rights, ¥2.829 million, was completed on 8 January 2021.」
Compared with its previous policy of primarily relying on internal funds and operating cash flow, the company raised external funds through a private placement of stock acquisition rights, with repayment of borrowings included among the uses of funds. - FY2021-Q2SoftenedAnnual report
「Cash flow from financing activities for the first 6 months of the current consolidated fiscal year was an inflow of ¥3,001.294 million, due mainly to an increase of ¥3,000 million in short-term borrowings and proceeds of ¥1.339 million from the exercise of stock options, compared with an outflow of ¥9.677 million in the same period of the previous year.」
Compared with its previous policy of primarily relying on internal funds and operating cash flow, cash inflows from financing activities resulting from increased short-term borrowings reached ¥3 billion, placing a greater emphasis on securing liquidity through external borrowings. - FY2021-Q1SoftenedAnnual report
「The company drew down borrowings as follows in order to prepare for refunds of travel payments resulting from travel cancellations and the suspension of travel operations due to the spread of COVID-19.」
Compared with its policy of primarily relying on internal funds and operating cash flow, the company continued and expanded its reliance on external borrowings to fund refunds. - FY2020SoftenedAnnual report
「These funds are generally sourced from cash flow from operating activities, but the company’s basic policy is to borrow from financial institutions when necessary.」
Compared with its previous policy of primarily funding working capital and capital expenditures with internal funds, the company explicitly adopted borrowing as a basic policy in response to the sharp decline in demand, and used existing credit facilities and short-term borrowings. - FY2019First statedAnnual report
「The group primarily funds its working capital and capital expenditures with internal funds. Cash and cash equivalents at the end of the current consolidated fiscal year totaled ¥3,638.155 million, securing sufficient funding and liquidity for future needs.」
The company states its policy of primarily funding working capital and capital expenditures with internal funds, while maintaining liquidity through cash and cash equivalents of ¥3,638.155 million at fiscal year-end.